Move follows FDA concerns about drug's health risks
For people age 12 and older
Condition affects 1 in 10 women of childbearing age
Slows virus that causes deadly liver disease
For postmenopausal women
But an agency official denies the accusation
Prevents rupture of aortic weak spot
Some patients quit cox-2 therapy; others have cut back as questions remain
With radiation, Temodar can extend patients' lives, FDA says
First Type 1 treatment since insulin
New England Journal of Medicine article claims agency too tied to industry
Less show, more show-and-tell seen in wake of drug safety hearings
300,000 Americans infected with both
Group says some children suffer rare, deadly syndrome after taking it
Blood pressure drug assumes dual role
The painkillers' problems haven't gone away, they say
Advisers vote to recommend keeping Celebrex, Vioxx and Bextra available while finding all raise cardiovascular risks
Tames rare skin infection
Hearing gets personal tales of pain relief with cox-2s
Vioxx increases heart dangers dramatically, Graham tells government advisers
First of three days of testimony gets underway
Results will be focus of three days of government hearings
Other research finds more evidence of heart attack, stroke risk
Panel must balance health risks against benefits
As many as 40 percent of cases may have been fatal, FDA scientist contends
Advisers cite need for medical supervision when taking statins
FDA offers some advice
It also suggests stricter regulation of dietary supplements
Agency says it will look at studies of COX-2 and COX-1 inhibitors
Will review heart safety of all cox-2 inhibitors
Thwarts debilitating mouth sores
Treats benign growths that obstruct breathing
Shows few signs of addictive side effects
Patient trials showed little blood glucose change
German-made vaccine procured under investigational drug application
Effort is last of four measures to head off bioterror threat
Condition affects up to 20 million Americans
May thwart pre-cancerous condition
Experts still see a key role for cox-2 inhibitors
Approves registry to protect women of childbearing age
Ensures operation is done on correct patient
FDA, pharmaceuticals defend process after insider names questionable medications
Extended life for some in trials
Officials rebut charges they dragged feet on dangerous medications
Agency denies pressure to put tough label on abortion pill
FDA, pharmaceutical measure aims to curtail counterfeiting
OK to combine with chemo after tumor removal
New drug helps manage phosphorus levels
To help ease lower back pain
Not intended for childbearing women